Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • pandemic preparedness

    - PMLiVE

    BioNTech announces £1bn UK investment to boost regional R&D presence

    The UK government has also agreed to award the company a grant of up to £129m

    - PMLiVE

    Sanofi unveils $20bn US investment to boost R&D and manufacturing presence

    The company is the latest major drugmaker to announce a significant investment in the country

    - PMLiVE

    UKHSA releases list of pathogens posing ‘greatest risk’ to public health

    The agency has listed 24 pathogen families where preparedness efforts are most needed

    - PMLiVE

    Johnson & Johnson to invest more than $55bn in US over next four years

    The commitment marks a 25% increase to the company's US investments in the past four years

    - PMLiVE

    WHO urges US to ‘reconsider’ withdrawal from global health organisation

    President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

    - PMLiVE

    WHO launches $1.5bn emergency appeal to tackle ongoing health crises

    The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people

    - PMLiVE

    AstraZeneca announces $3.5bn US investment to boost research and manufacturing

    The commitment is part of the company’s ambition to achieve $80bn in total revenue by 2030

    - PMLiVE

    WHO announces priority endemic pathogens for urgent vaccine development

    The study identifies the 17 pathogens that regularly cause diseases in communities

    - PMLiVE

    WHO announces new mRNA vaccine development initiative against human avian influenza

    H5N1 was responsible for 889 cases and 463 deaths across 23 countries from 2003 to 2024

    - PMLiVE

    WHO and CEPI call for broader research strategy to prepare for future pandemics

    They have highlighted the importance of expanding research to entire families of pathogens

    - PMLiVE

    WHO calls for better medicines access to close neurological disorders treatment gap

    In 2021, neurological conditions affected more than three billion people worldwide

    - PMLiVE

    WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer

    In more than nine out of ten cases, the HPV virus leads to cervical cancer, the fourth most common cancer in women globally

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links